Six years after first allying with Aelix Therapeutics to test the Spanish biotech’s HTI vaccine for HIV, Gilead Sciences has decided to buy the vaccine program. | Six years after first allying with Aelix Therapeutics to test the Spanish biotech’s HTI vaccine for HIV, Gilead Sciences has decided to buy the vaccine program.
Food safety experts say safely serving a holiday feast takes planning and know-how. Outbreaks of some types of food poisoning tend to rise in November…
Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment
The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such as influenza, COVID-19, respiratory syncytial virus (RSV), and…
Coadministered mRNA-1345 plus SIIV4 or mRNA-1273.214 vaccines had acceptable safety profiles and elicited mostly non-inferior immune responses compared to individual vaccines in adults aged 50…
In Ethiopia’s Tigray region, an FHI 360 local partner played a critical role in helping people living with HIV regain access to their antiretroviral therapy…
Using faecal microbiota transplantation within the CGA framework further enhanced survival and care efficiency.
This World AIDS Day, let’s combine our forces to build a truly equitable HIV response that reaches all.
COVID-19 vaccination results in high antibody response and low rates of hospitalization among children with IBD.
Tuberculosis (TB) affects 10 million people worldwide and causes 1.5 million deaths annually, making it the leading infectious cause of death worldwide.(1) An estimated 25%…
Compared with men, women who switched to INSTI-based ART for HIV management experienced greater weight gain over 5 years.
